切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (04) : 303 -308. doi: 10.3877/cma.j.issn.2095-3224.2016.04.005

所属专题: 专题评论 文献

专家论坛

MRI在直肠癌新辅助治疗疗效评估中的价值
张翀达1, 张红梅1,()   
  1. 1. 100021 北京,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院影像诊断科
  • 收稿日期:2016-06-07 出版日期:2016-08-25
  • 通信作者: 张红梅

MR imaging in the evaluation of tumor response after neoadjuvant chemoradiotherapy for patients with rectal cancers

Chongda Zhang1, Hongmei Zhang1,()   

  1. 1. Department of Diagnostic Radiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
  • Received:2016-06-07 Published:2016-08-25
  • Corresponding author: Hongmei Zhang
  • About author:
    Corresponding author: Zhang Hongmei, Email:
引用本文:

张翀达, 张红梅. MRI在直肠癌新辅助治疗疗效评估中的价值[J]. 中华结直肠疾病电子杂志, 2016, 05(04): 303-308.

Chongda Zhang, Hongmei Zhang. MR imaging in the evaluation of tumor response after neoadjuvant chemoradiotherapy for patients with rectal cancers[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(04): 303-308.

直肠癌新辅助放化疗可使肿瘤出现不同程度的消退,部分病灶甚至可以达到病理完全缓解,从而提高外科手术切除率,降低局部复发率。对肿瘤新辅助治疗疗效的准确评估,是选择个体化治疗方案的关键。磁共振成像对于直肠癌术前分期的价值得到广泛认可,其在新辅助治疗疗效评估中的作用仍在持续研究中。肿瘤体积测量是传统的应用评价指标,但繁琐的测量与计算过程一定程度上限制了其临床应用。多种功能成像序列的发展,为新辅助放化疗后疗效评估提供了更多更有效的选择方式。尽管如此,MRI对于分辨极少量残存的肿瘤细胞仍具有一定的困难,尤其是对于治疗后肿瘤完全缓解的评价,尚有待进一步研究与探索。

Multidisciplinary management of rectal cancer has evolved significantly, leading to the particular importance of neoadjuvant therapy. Concurrently improving the resectability, neoadjuvant therapy may lead to an effective tumor down-staging of locally advanced rectal cancer in varying degrees. It is significant to assess tumor response after neadjuvant therapy for altering the subsequent treatment options that are considered. Magnetic resonance imaging is the recommended imaging technique for local staging of rectal cancer before surgery, and the role which plays in evaluation of response to neoadjuvant therapy is still under study. The value of conventional MR depends on morphological changes in assessment of therapeutic effect. Nevertheless, there are still some limitations. Functional MR combines information of detailed anatomy with that of tumor biology, providing comprehensive status on tumor morphological features, quantitative indicators and their changes as a result of treatment. It has the potential to assess the response to neoadjuvant therapy more accurately.

[1]
Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015 [J]. CA: a cancer journal for clinicians, 2016, 66(2):115-132.
[2]
梁晓,张红梅,叶枫, 等. 扩散加权成像在预测直肠癌术前放化疗疗效中的价值 [J].中华肿瘤杂志, 2016, 38(2):133-137.
[3]
Mckeown E, Nelson D W, Johnson E K, et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer [J]. J Cancer, 2014, 5(1):31-43.
[4]
Ferrari L, Fichera A. Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer [J]. Gastroenterology report, 2015, 3(4):277-288.
[5]
Hartley A, Ho K F, Mcconkey C, et al. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials [J]. The British journal of radiology, 2005, 78(934):934-938.
[6]
Huh J W, Kim H C, Lee S J, et al. Diagnostic accuracy and prognostic impact of restaging by magnetic resonance imaging after preoperative chemoradiotherapy in patients with rectal cancer [J]. Radiotherapy and Oncology, 2014, 113(1):24-28.
[7]
Petrillo M, Fusco R, Catalano O, et al. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report [J]. BioMed Res int, 2015:514740
[8]
Kluza E, Rozeboom E D, Maas M, et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer [J]. European radiology, 2013, 23(1):253-261.
[9]
Habr Gama A, Perez R O. Non‐operative management of rectal cancer after neoadjuvant chemoradiation[J]. British Journal of Surgery,2009, 96(2):125-127.
[10]
O′Neill B D, Brown G, Heald R J, et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer [J]. The lancet oncology, 2007, 8(7):625-633.
[11]
Jang K M, Kim S H, Choi D, et al. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results [J]. The British journal of radiology,2012, 85(1017):e566-572
[12]
Beets-Tan R G, Beets G L. MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer [J]. Nature Reviews Gastroenterology & Hepatology, 2014, 11(8):480-488.
[13]
Chand M, Swift R I, Tekkis P P, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer [J]. British journal of cancer, 2014, 110(1):19-25.
[14]
Kim S H, Chang H J, Kim D Y, et al. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?[J]. Cancer Research and Treatment, 2015, 254. [Epub ahead of print]
[15]
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy [J]. International journal of colorectal disease, 1997, 12(1):19-23.
[16]
Lee J H, Jang H S, Kim J, et al. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02[J]. Radiotherapy and Oncology,2014,113(1):18-23.
[17]
van der Paardt M P, Zagers M B, Beets-Tan R G, et al. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis [J]. Radiology, 2013, 269(1):101-112.
[18]
Pierredon-Foulongne M, Nougaret S, Bibeau F, et al. Utility of reassessment after neoadjuvant therapy and difficulties in interpretation [J]. Diagnostic and interventional imaging, 2014, 95(5):495-503.
[19]
Battersby N J, Moran B, Yu S, et al. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy [J]. Expert review of gastroenterology & hepatology, 2014, 8(6):703-719.
[20]
黄忠明,初丽丽,赵日升, 等. 磁共振成像对直肠癌术前放化疗后再分期准确性的Meta分析 [J].中华胃肠外科杂志, 2014, 17(3):258-263.
[21]
Wen B, Zhang L, Wang C, et al. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy [J]. Radiation Oncology, 2015, 10(1):124.
[22]
Barbaro B, Fiorucci C, Tebala C, et al. Locally Advanced Rectal Cancer: MR Imaging in Prediction of Response after Preoperative Chemotherapy and Radiation Therapy [J]. Radiology, 2009, 250(3):730-739.
[23]
Nougaret S, Fujii S, Addley H C, et al. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience [J]. Journal of Magnetic Resonance Imaging, 2013, 38(3):726-732.
[24]
Ha H I, Kim A Y, Yu C S, et al. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy [J]. European radiology, 2013, 23(12):3345-3353.
[25]
Birlik B, Obuz F, Elibol F D, et al. Diffusion-weighted MRI and MR-volumetry-in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer [J]. Magnetic resonance imaging, 2015, 33(2):201-212.
[26]
Kim Y C, Lim J S, Keum K C, et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer [J]. Journal of Magnetic Resonance Imaging, 2011, 34(3):570-576.
[27]
Curvo-Semedo L, Lambregts D M, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging [J]. Radiology, 2011, 260(3):734-743.
[28]
Tong T, Sun Y, Gollub M J, et al. Dynamic contrast‐enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer [J]. Journal of Magnetic Resonance Imaging, 2015, 42(3):673-680.
[29]
Song I, Kim S H, Lee S J, et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging [J]. The British journal of radiology, 2012, 85(1013):577-586.
[30]
Kim S H, Lee J M, Hong S H, et al. Locally Advanced Rectal Cancer: Added Value of Diffusion-weighted MR Imaging in the Evaluation of Tumor Response to Neoadjuvant Chemo-and Radiation Therapy [J]. Radiology, 2009, 253(1):116-125.
[31]
Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results [J]. International Journal of Radiation Oncology • Biology • Physics, 2012, 82(2):863-870.
[32]
Blažić I, Maksimović R, Gajić M, et al. Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy [J]. Croatian medical journal, 2015, 56(5):460-469.
[33]
Lambregts D M, Beets G L, Maas M, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability [J]. European radiology, 2011, 21(12):2567-2574.
[34]
Nougaret S, Vargas H A, Lakhman Y, et al. Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses [J]. Radiology, 2016:150702.
[35]
童彤,孙轶群,蔡三军, 等. 动态对比增强MRI预测局部进展期直肠癌新辅助放化疗疗效的价值[J]. 中华放射学杂志, 2015(6):414-418.
[36]
周妮娜,陈敏,王文超, 等. 动态增强磁共振成像对直肠癌术前新辅助治疗疗效的评价 [J]. 磁共振成像, 2010, 1(2):103-109.
[37]
Cai P, Wu Y, An X, et al. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer [J]. European radiology, 2014, 24(11):2962-2970.
[38]
Fujii S, Nougaret S, Escal L, et al. MR imaging of locally advanced low rectal cancer: Relationships between imaging findings and the pathological tumor regression grade [J]. Journal of Magnetic Resonance Imaging, 2015, 42(2):421-426.
[1] 丁建民, 秦正义, 张翔, 周燕, 周洪雨, 王彦冬, 经翔. 超声造影与普美显磁共振成像对具有高危因素的≤3 cm肝结节进行LI-RADS分类诊断的前瞻性研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 930-938.
[2] 张莲莲, 惠品晶, 丁亚芳. 颈部血管超声在粥样硬化斑块易损性评估中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 816-821.
[3] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[4] 张华, 孙宇, 乡世健, 李樱媚, 王小群. 循环肿瘤细胞预测晚期胃肠癌患者化疗药物敏感性的研究[J]. 中华普通外科学文献(电子版), 2023, 17(06): 422-425.
[5] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[6] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[7] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[8] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[9] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[10] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[11] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[12] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[13] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 李莹倩, 李华山. 基于真实世界的完全性直肠脱垂治疗方式评价[J]. 中华临床医师杂志(电子版), 2023, 17(06): 700-705.
阅读次数
全文


摘要